Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit
- PMID: 31548097
- DOI: 10.1016/j.jacc.2019.07.077
Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit
Abstract
Background: A new 5-stage cardiogenic shock (CS) classification scheme was recently proposed by the Society for Cardiovascular Angiography and Intervention (SCAI) for the purpose of risk stratification.
Objectives: This study sought to apply the SCAI shock classification in a cardiac intensive care unit (CICU) population.
Methods: The study retrospectively analyzed Mayo Clinic CICU patients admitted between 2007 and 2015. SCAI CS stages A through E were classified retrospectively using CICU admission data based on the presence of hypotension or tachycardia, hypoperfusion, deterioration, and refractory shock. Hospital mortality in each SCAI shock stage was stratified by cardiac arrest (CA).
Results: Among the 10,004 unique patients, 43.1% had acute coronary syndrome, 46.1% had heart failure, and 12.1% had CA. The proportion of patients in SCAI CS stages A through E was 46.0%, 30.0%, 15.7%, 7.3%, and 1.0% and unadjusted hospital mortality in these stages was 3.0%, 7.1%, 12.4%, 40.4%, and 67.0% (p < 0.001), respectively. After multivariable adjustment, each higher SCAI shock stage was associated with increased hospital mortality (adjusted odds ratio: 1.53 to 6.80; all p < 0.001) compared with SCAI shock stage A, as was CA (adjusted odds ratio: 3.99; 95% confidence interval: 3.27 to 4.86; p < 0.001). Results were consistent in the subset of patients with acute coronary syndrome or heart failure.
Conclusions: When assessed at the time of CICU admission, the SCAI CS classification, including presence or absence of CA, provided robust hospital mortality risk stratification. This classification system could be implemented as a clinical and research tool to identify, communicate, and predict the risk of death in patients with, and at risk for, CS.
Keywords: cardiac intensive care unit; cardiogenic shock; critical care; mortality; shock.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
The SCAI Cardiogenic Shock Staging System Gets Taken for a Test Drive.J Am Coll Cardiol. 2019 Oct 29;74(17):2129-2131. doi: 10.1016/j.jacc.2019.08.1020. Epub 2019 Sep 20. J Am Coll Cardiol. 2019. PMID: 31548098 No abstract available.
Similar articles
-
Admission Society for Cardiovascular Angiography and Intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patients.Am Heart J. 2020 Jan;219:37-46. doi: 10.1016/j.ahj.2019.10.012. Epub 2019 Oct 27. Am Heart J. 2020. PMID: 31710843
-
Influence of cardiac arrest and SCAI shock stage on cardiac intensive care unit mortality.Catheter Cardiovasc Interv. 2020 Dec;96(7):1350-1359. doi: 10.1002/ccd.28854. Epub 2020 Mar 17. Catheter Cardiovasc Interv. 2020. PMID: 32180344
-
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients.Circ Cardiovasc Qual Outcomes. 2020 Dec;13(12):e006956. doi: 10.1161/CIRCOUTCOMES.120.006956. Epub 2020 Dec 7. Circ Cardiovasc Qual Outcomes. 2020. PMID: 33280435
-
Cardiogenic Shock Classification and Associated Mortality Risk.Mayo Clin Proc. 2023 May;98(5):771-783. doi: 10.1016/j.mayocp.2022.12.007. Epub 2023 Apr 5. Mayo Clin Proc. 2023. PMID: 37028976 Review.
-
Mechanical circulatory support in patients with cardiogenic shock in intensive care units: A position paper of the "Unité de Soins Intensifs de Cardiologie" group of the French Society of Cardiology, endorsed by the "Groupe Athérome et Cardiologie Interventionnelle" of the French Society of Cardiology.Arch Cardiovasc Dis. 2018 Oct;111(10):601-612. doi: 10.1016/j.acvd.2018.03.008. Epub 2018 Jun 11. Arch Cardiovasc Dis. 2018. PMID: 29903693 Review.
Cited by
-
Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial.Trials. 2024 Oct 30;25(1):731. doi: 10.1186/s13063-024-08567-y. Trials. 2024. PMID: 39478521 Free PMC article.
-
Society of Cardiovascular Angiography and intervention Stage-B cardiogenic shock: An interventional-heart failure-critical care conundrum.IHJ Cardiovasc Case Rep. 2023 Jul-Dec;7(3-4):76-80. doi: 10.1016/j.ihjccr.2023.07.002. Epub 2023 Jul 5. IHJ Cardiovasc Case Rep. 2023. PMID: 39450159 Free PMC article.
-
Non-acute myocardial infarction-associated cardiogenic shock in Hispanic patients: An analysis from the National Inpatient Sample Database.Am Heart J Plus. 2024 Sep 21;46:100462. doi: 10.1016/j.ahjo.2024.100462. eCollection 2024 Oct. Am Heart J Plus. 2024. PMID: 39351148 Free PMC article.
-
SCAI Cardiogenic Shock Classification for Predicting In-Hospital and Long-Term Mortality in Acute Heart Failure.J Soc Cardiovasc Angiogr Interv. 2022 Oct 1;1(6):100496. doi: 10.1016/j.jscai.2022.100496. eCollection 2022 Nov-Dec. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132349 Free PMC article.
-
SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021.J Soc Cardiovasc Angiogr Interv. 2022 Jan 30;1(1):100008. doi: 10.1016/j.jscai.2021.100008. eCollection 2022 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39130139 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
